Literature DB >> 25570934

Techniques and applications of dynamic contrast enhanced magnetic resonance imaging in cancer.

Stephanie L Barnes, Jennifer G Whisenant, Thomas E Yankeelov.   

Abstract

We first discuss several key technical issues associated with quantitative dynamic contrast enhanced magnetic resonance imaging (DCE-MRI), and then provide examples of DCE-MRI in oncology. In particular, we examine the importance of both active and passive delivery of the contrast agent to the tissue under investigation, and repeatability/reproducibility in DCE-MRI studies. We then discuss examples of how DCE-MRI can assist in assessing and predicting therapeutic response in the neoadjuvant setting.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25570934      PMCID: PMC4428286          DOI: 10.1109/EMBC.2014.6944566

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  24 in total

1.  Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model.

Authors:  Thomas E Yankeelov; Jeffrey J Luci; Martin Lepage; Rui Li; Laura Debusk; P Charles Lin; Ronald R Price; John C Gore
Journal:  Magn Reson Imaging       Date:  2005-05       Impact factor: 2.546

2.  Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

Authors:  Nola M Hylton; Jeffrey D Blume; Wanda K Bernreuter; Etta D Pisano; Mark A Rosen; Elizabeth A Morris; Paul T Weatherall; Constance D Lehman; Gillian M Newstead; Sandra Polin; Helga S Marques; Laura J Esserman; Mitchell D Schnall
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

3.  A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.

Authors:  Xia Li; E Brian Welch; Lori R Arlinghaus; A Bapsi Chakravarthy; Lei Xu; Jaime Farley; Mary E Loveless; Ingrid A Mayer; Mark C Kelley; Ingrid M Meszoely; Julie A Means-Powell; Vandana G Abramson; Ana M Grau; John C Gore; Thomas E Yankeelov
Journal:  Phys Med Biol       Date:  2011-08-12       Impact factor: 3.609

4.  Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.

Authors:  Susan M Galbraith; Martin A Lodge; N Jane Taylor; Gordon J S Rustin; Søren Bentzen; J James Stirling; Anwar R Padhani
Journal:  NMR Biomed       Date:  2002-04       Impact factor: 4.044

5.  A comparison of dynamic contrast-enhanced CT and MR imaging-derived measurements in patients with cervical cancer.

Authors:  Sun Mo Kim; Masoom A Haider; Michael Milosevic; Ivan W T Yeung
Journal:  Clin Physiol Funct Imaging       Date:  2012-11-27       Impact factor: 2.273

6.  A diffusion-compensated model for the analysis of DCE-MRI data: theory, simulations and experimental results.

Authors:  Jacob U Fluckiger; Mary E Loveless; Stephanie L Barnes; Martin Lepage; Thomas E Yankeelov
Journal:  Phys Med Biol       Date:  2013-03-04       Impact factor: 3.609

7.  Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results.

Authors:  Anwar R Padhani; Carmel Hayes; Laura Assersohn; Trevor Powles; Andreas Makris; John Suckling; Martin O Leach; Janet E Husband
Journal:  Radiology       Date:  2006-03-16       Impact factor: 11.105

8.  Incorporating contrast agent diffusion into the analysis of DCE-MRI data.

Authors:  Martin Pellerin; Thomas E Yankeelov; Martin Lepage
Journal:  Magn Reson Med       Date:  2007-12       Impact factor: 4.668

9.  Colorectal liver metastases: contrast agent diffusion coefficient for quantification of contrast enhancement heterogeneity at MR imaging.

Authors:  Guang Jia; Craig O'Dell; Johannes T Heverhagen; Xiangyu Yang; Jiachao Liang; Richard V Jacko; Steffen Sammet; Theodore Pellas; Patricia Cole; Michael V Knopp
Journal:  Radiology       Date:  2008-09       Impact factor: 11.105

10.  DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.

Authors:  Xia Li; Lori R Arlinghaus; Gregory D Ayers; A Bapsi Chakravarthy; Richard G Abramson; Vandana G Abramson; Nkiruka Atuegwu; Jaime Farley; Ingrid A Mayer; Mark C Kelley; Ingrid M Meszoely; Julie Means-Powell; Ana M Grau; Melinda Sanders; Sandeep R Bhave; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2013-05-09       Impact factor: 4.668

View more
  7 in total

1.  Comparison of arterial input functions measured from ultra-fast dynamic contrast enhanced MRI and dynamic contrast enhanced computed tomography in prostate cancer patients.

Authors:  Shiyang Wang; Zhengfeng Lu; Xiaobing Fan; Milica Medved; Xia Jiang; Steffen Sammet; Ambereen Yousuf; Federico Pineda; Aytekin Oto; Gregory S Karczmar
Journal:  Phys Med Biol       Date:  2018-01-30       Impact factor: 3.609

2.  Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.

Authors:  Ziliang Cheng; Zhuo Wu; Guangzi Shi; Zhilong Yi; Mingwei Xie; Weike Zeng; Chao Song; Chushan Zheng; Jun Shen
Journal:  Eur Radiol       Date:  2017-09-19       Impact factor: 5.315

3.  The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma.

Authors:  Xiang Xu; Jiadi Xu; Linda Knutsson; Jing Liu; Huanling Liu; Yuguo Li; Bachchu Lal; John Laterra; Dmitri Artemov; Guanshu Liu; Peter C M van Zijl; Kannie W Y Chan
Journal:  Magn Reson Med       Date:  2019-02-22       Impact factor: 4.668

4.  Can Dynamic Contrast-Enhanced MRI (DCE-MRI) and Diffusion-Weighted MRI (DW-MRI) Evaluate Inflammation Disease: A Preliminary Study of Crohn's Disease.

Authors:  Jianguo Zhu; Faming Zhang; Yun Luan; Peng Cao; Fei Liu; Wenwen He; Dehang Wang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Review of MR-Guided Radiotherapy for Esophageal Cancer.

Authors:  Sangjune Laurence Lee; Michael Bassetti; Gert J Meijer; Stella Mook
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

6.  Applying dynamic contrast enhanced MSOT imaging to intratumoral pharmacokinetic modeling.

Authors:  Ted G Xiao; Jared A Weis; F Scott Gayzik; Alexandra Thomas; Akiko Chiba; Metin N Gurcan; Umit Topaloglu; Abhilash Samykutty; Lacey R McNally
Journal:  Photoacoustics       Date:  2018-07-27

7.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Monoclonal Antibody Tumor Disposition.

Authors:  Brandon M Bordeau; Joseph Ryan Polli; Ferdinand Schweser; Hans Peter Grimm; Wolfgang F Richter; Joseph P Balthasar
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.